| | | Single nucleotide variant (missense variant) | Generalized epilepsy with febrile seizures plus type 5 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense) | Neural tube defects, folate-sensitive +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Parkinson disease 6 | |
| | | Single nucleotide variant (intron variant) | Hypertension, essential, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Hypertension, essential, susceptibility to | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Prostate cancer/brain cancer susceptibility | |
| | RSRP1, RHD (G355S +1 more) | Single nucleotide variant (non-coding transcript variant +2 more) | Anti-D isoimmunization affecting pregnancy +1 more | |
| | | Single nucleotide variant (intron variant) | Rheumatic heart disease | |
| | | Single nucleotide variant (synonymous variant) | Bardet-Biedl syndrome +1 more | GUncertain significance; risk factor |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 12 | |
| | | Single nucleotide variant (missense variant) | Aortic aneurysm, familial thoracic 11, susceptibility to +2 more | GLikely pathogenic; risk factor |
| | | Single nucleotide variant (missense variant) | Encephalopathy, acute, infection-induced, susceptibility to, 4 | |
| | | Single nucleotide variant (missense variant) | Myocardial infarction 1 | |
| | | Single nucleotide variant (3 prime UTR variant) | Estrogen resistance syndrome | |
| | | Single nucleotide variant (non-coding transcript variant) | Autoimmune disease, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense) | Multisystem inflammatory syndrome in children | |
| | | Single nucleotide variant (nonsense +1 more) | Multisystem inflammatory syndrome in children | |
| | | Single nucleotide variant (intron variant) | Diamond-Blackfan anemia 6 | |
| | | Single nucleotide variant (genic upstream transcript variant) | Myocardial infarction, susceptibility to | |
| | | Single nucleotide variant | Diabetes mellitus, insulin-dependent, susceptibility to | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | GUncertain significance; risk factor |
| | | Single nucleotide variant (missense variant) | Neural tube defects, susceptibility to | |
| | GBA1, LOC106627981 (L483P +2 more) | Single nucleotide variant (missense variant) | GBA1-related disorder +15 more | |
| | GBA1, LOC106627981 (N409S +2 more) | Single nucleotide variant (missense variant) | Rigidity +13 more | GPathogenic/Likely pathogenic; risk factor |
| | GBA1, LOC106627981 (E365K +2 more) | Single nucleotide variant (missense variant) | Parkinson disease, late-onset +13 more | GBenign/Likely benign; risk factor |
| | | Single nucleotide variant (missense variant) | Neural tube defects, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Neural tube defects, susceptibility to | |
| | CD84, LOC105371468 (Y107fs) | Deletion (frameshift variant +1 more) | Multisystem inflammatory syndrome in children | |
| | | Deletion (frameshift variant) | Multisystem inflammatory syndrome in children | |
| | | Single nucleotide variant (intron variant) | Rheumatoid arthritis | |
| | | Single nucleotide variant (3 prime UTR variant) | Hyperlipidemia, familial combined, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Hyperlipidemia, familial combined, susceptibility to | |
| | | Single nucleotide variant (genic upstream transcript variant) | Systemic lupus erythematosus, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Malaria, resistance to +1 more | |
| | | Single nucleotide variant (missense variant) | Deafness, autosomal recessive 26, modifier of | |
| | | Single nucleotide variant | LUNG CANCER, SUSCEPTIBILITY TO | |
| | | Deletion (frameshift variant) | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | |
| | | Single nucleotide variant (no sequence alteration) | Age related macular degeneration 4 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Age related macular degeneration 4 | |
| | | Single nucleotide variant (genic downstream transcript variant +1 more) | Age related macular degeneration 4 | |
| | | Single nucleotide variant (nonsense) | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense) | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense) | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Atypical hemolytic-uremic syndrome +1 more | |
| | | Deletion (stop lost) | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | |
| | | Deletion | Age-related macular degeneration +1 more | |
| | | Single nucleotide variant (intron variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 | |
| | | Single nucleotide variant | Asthma-related traits, susceptibility to, 7 | |
| | | Single nucleotide variant (synonymous variant +2 more) | Systemic lupus erythematosus, susceptibility to, 9 | |
| | | Single nucleotide variant (splice acceptor variant) | Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | |
| | | Microsatellite (frameshift variant) | Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | |
| | | Deletion (inframe_deletion) | Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | |
| | | Single nucleotide variant (nonsense) | Melioidosis, resistance to +2 more | |
| | | Single nucleotide variant (nonsense +1 more) | Rhabdomyolysis, susceptibility to, 1 | |
| | | Deletion (frameshift variant) | Rhabdomyolysis, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense) | Rhabdomyolysis, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense) | Rhabdomyolysis, susceptibility to, 1 | |
| | DISC1, TSNAX-DISC1 (R264Q) | Single nucleotide variant (non-coding transcript variant +2 more) | Schizophrenia 9 | |
| | ANKRD34A, ANKRD35 +11 more | Copy number loss | Cerebral palsy | |
| | | Single nucleotide variant | Obesity | |
| | ADCY3, CENPO (F1118del +4 more) | Microsatellite (inframe_deletion +2 more) | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19 | |
| | ADCY3, CENPO (I1107fs +4 more) | Deletion (frameshift variant +2 more) | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19 | |
| | | Single nucleotide variant (splice acceptor variant) | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19 | |
| | | Single nucleotide variant (intron variant +1 more) | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19 | |
| | | Deletion (frameshift variant) | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +2 more | GPathogenic/Likely pathogenic; risk factor |
| | | Single nucleotide variant (missense variant) | SPAST-related disorder +5 more | GBenign/Likely benign; other; risk factor |
| | | Duplication (frameshift variant) | Schizophrenia 17 | |
| | | Single nucleotide variant (missense variant +1 more) | Bardet-Biedl syndrome 12, modifier of | |
| | | Single nucleotide variant (missense variant +1 more) | Meckel syndrome, type 6, modifier of | |
| | | Single nucleotide variant (missense variant) | Capillary infantile hemangioma | |
| | | Single nucleotide variant (missense variant +1 more) | Perry syndrome +1 more | GUncertain significance; risk factor |
| | | Single nucleotide variant (missense variant +1 more) | Parkinson disease 13, autosomal dominant, susceptibility to | |
| | | Duplication (frameshift variant) | Pheochromocytoma +1 more | GLikely pathogenic; risk factor |
| | | Single nucleotide variant (missense variant) | Familial acute necrotizing encephalopathy | |
| | | Single nucleotide variant | Gastric cancer susceptibility after h. pylori infection | |
| | | Microsatellite (intron variant) | Gastric cancer susceptibility after h. pylori infection +1 more | |
| | | Single nucleotide variant (missense variant) | Hypogonadotropic hypogonadism 15 with anosmia | |
| | | Single nucleotide variant (missense variant) | Hypogonadotropic hypogonadism 15 with anosmia | |
| | | Single nucleotide variant (nonsense) | Epilepsy, juvenile myoclonic, susceptibility to, 6 | |
| | | Single nucleotide variant (intron variant) | Systemic lupus erythematosus, susceptibility to, 11 | |
| | | Single nucleotide variant (synonymous variant) | Mycobacterium tuberculosis, susceptibility to infection by | |
| | | Single nucleotide variant (missense variant) | Buruli ulcer, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Insulin resistance, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Parkinson disease 11, autosomal dominant, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Parkinson disease 11, autosomal dominant, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Parkinson disease 11, autosomal dominant, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Parkinson disease 11, autosomal dominant, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Type 2 diabetes mellitus 1, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Type 2 diabetes mellitus 1, susceptibility to | |
| | | Duplication (intron variant) | Type 2 diabetes mellitus 1, susceptibility to | |
| | | Single nucleotide variant | Type 2 diabetes mellitus 1, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Systemic lupus erythematosus, association wit 2 +1 more | |
| | | Single nucleotide variant (missense variant) | Long QT syndrome 9, acquired, susceptibility to | |
| | | Single nucleotide variant (missense variant +1 more) | Atrioventricular septal defect, susceptibility to, 2 | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Atrioventricular septal defect, susceptibility to, 2 | |
| | GHRL, GHRLOS (R51Q +3 more) | Single nucleotide variant (missense variant +1 more) | Obesity +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Diabetes mellitus, noninsulin-dependent, modifier of +3 more | |